BR0008269A - Uso de uma preparação de m. vaccae, e, método para tratamento de infecção viral crÈnica, excluindo infecção por hiv - Google Patents
Uso de uma preparação de m. vaccae, e, método para tratamento de infecção viral crÈnica, excluindo infecção por hivInfo
- Publication number
- BR0008269A BR0008269A BR0008269-4A BR0008269A BR0008269A BR 0008269 A BR0008269 A BR 0008269A BR 0008269 A BR0008269 A BR 0008269A BR 0008269 A BR0008269 A BR 0008269A
- Authority
- BR
- Brazil
- Prior art keywords
- infection
- chronic viral
- vaccae
- treatment
- excluding
- Prior art date
Links
- 230000009385 viral infection Effects 0.000 title abstract 5
- 208000036142 Viral infection Diseases 0.000 title abstract 4
- 230000001684 chronic effect Effects 0.000 title abstract 4
- 208000031886 HIV Infections Diseases 0.000 title abstract 3
- 208000037357 HIV infectious disease Diseases 0.000 title abstract 3
- 241000187644 Mycobacterium vaccae Species 0.000 title abstract 3
- 208000033519 human immunodeficiency virus infectious disease Diseases 0.000 title abstract 3
- 239000003814 drug Substances 0.000 title abstract 2
- 238000000034 method Methods 0.000 title abstract 2
- 229940079593 drug Drugs 0.000 title 1
- 208000009608 Papillomavirus Infections Diseases 0.000 abstract 2
- 206010008263 Cervical dysplasia Diseases 0.000 abstract 1
- 208000029433 Herpesviridae infectious disease Diseases 0.000 abstract 1
- 208000037065 Subacute sclerosing leukoencephalitis Diseases 0.000 abstract 1
- 206010042297 Subacute sclerosing panencephalitis Diseases 0.000 abstract 1
- 208000006454 hepatitis Diseases 0.000 abstract 1
- 231100000283 hepatitis Toxicity 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/04—Mycobacterium, e.g. Mycobacterium tuberculosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55588—Adjuvants of undefined constitution
- A61K2039/55594—Adjuvants of undefined constitution from bacteria
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Virology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Communicable Diseases (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Oncology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Dermatology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
"USO DE UMA PREPARAçãO DE M. VACCAE, E, MéTODO PARA TRATAMENTO DE INFECçãO VIRAL CRÈNICA, EXCLUINDO INFECçãO POR HIV". A presente invenção provê o uso de preparação de M.vaccae para a fabricação de um medicamento para uso no tratamento de uma infecção viral crónica, excluindo uma infecção por HIV. As infecções virais crónicas incluem infecção por HPV, como infecção por HPV associada com displasia cervical, infecção por virus do herpes, pan-encefalite esclerosante subaguda, e infecção por vírus de hepatite.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9903539.6A GB9903539D0 (en) | 1999-02-16 | 1999-02-16 | Therapy using M.Vaccae |
| PCT/GB2000/000544 WO2000048615A2 (en) | 1999-02-16 | 2000-02-16 | TREATMENT OF CHRONIC VIRAL INFECTIONS WITH $i(M. VACCAE) |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR0008269A true BR0008269A (pt) | 2001-11-06 |
Family
ID=10847890
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR0008269-4A BR0008269A (pt) | 1999-02-16 | 2000-02-16 | Uso de uma preparação de m. vaccae, e, método para tratamento de infecção viral crÈnica, excluindo infecção por hiv |
Country Status (26)
| Country | Link |
|---|---|
| US (1) | US6596282B1 (pt) |
| EP (1) | EP1152768B1 (pt) |
| JP (1) | JP2002537266A (pt) |
| KR (1) | KR20010113691A (pt) |
| CN (1) | CN1377274A (pt) |
| AP (1) | AP2001002254A0 (pt) |
| AT (1) | ATE246930T1 (pt) |
| AU (1) | AU766113B2 (pt) |
| BR (1) | BR0008269A (pt) |
| CA (1) | CA2361925A1 (pt) |
| DE (1) | DE60004481T2 (pt) |
| DK (1) | DK1152768T3 (pt) |
| ES (1) | ES2204508T3 (pt) |
| GB (1) | GB9903539D0 (pt) |
| HK (1) | HK1038697B (pt) |
| HU (1) | HUP0105474A3 (pt) |
| ID (1) | ID30441A (pt) |
| MX (1) | MXPA01008243A (pt) |
| NO (1) | NO20013939L (pt) |
| NZ (1) | NZ513320A (pt) |
| PL (1) | PL350577A1 (pt) |
| PT (1) | PT1152768E (pt) |
| RU (1) | RU2001125429A (pt) |
| TR (1) | TR200102388T2 (pt) |
| WO (1) | WO2000048615A2 (pt) |
| ZA (1) | ZA200106248B (pt) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0010496D0 (en) * | 2000-04-28 | 2000-06-14 | Stanford Rook Ltd | Treatment of conditions of the central nervous system |
| US20070098746A1 (en) * | 2005-11-02 | 2007-05-03 | Nichols William M | Multi-layered coating technology for taste masking |
| CN111281893B (zh) * | 2020-03-02 | 2021-11-19 | 广西医科大学第一附属医院 | 注射用母牛分枝杆菌在制备用于防治covid-19的药物中的应用 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8917256D0 (en) | 1989-07-28 | 1989-09-13 | Univ London | Biological preparation and its use |
| GB9219425D0 (en) * | 1992-09-14 | 1992-10-28 | Univ London | Therapeutic agent and its use |
| GB8919321D0 (en) | 1989-08-25 | 1989-10-11 | Univ London | Treatment of chronic inflammatory conditions |
| EP0556248B1 (en) | 1990-11-08 | 1997-06-25 | University College London | Mycobacterium as adjuvant for antigens |
| HUP0100352A2 (hu) | 1997-12-23 | 2001-06-28 | Genesis Research & Development Corporation Limited | Mycobacterium vaccaeből származó kompozíciók és eljárások ezek alkalmazására |
-
1999
- 1999-02-16 GB GBGB9903539.6A patent/GB9903539D0/en not_active Ceased
-
2000
- 2000-02-16 KR KR1020017010289A patent/KR20010113691A/ko not_active Withdrawn
- 2000-02-16 HK HK02100237.1A patent/HK1038697B/en not_active IP Right Cessation
- 2000-02-16 BR BR0008269-4A patent/BR0008269A/pt not_active IP Right Cessation
- 2000-02-16 WO PCT/GB2000/000544 patent/WO2000048615A2/en not_active Ceased
- 2000-02-16 CN CN00803475A patent/CN1377274A/zh active Pending
- 2000-02-16 PT PT00903857T patent/PT1152768E/pt unknown
- 2000-02-16 JP JP2000599405A patent/JP2002537266A/ja active Pending
- 2000-02-16 ID IDW00200102000Q patent/ID30441A/id unknown
- 2000-02-16 PL PL00350577A patent/PL350577A1/xx not_active Application Discontinuation
- 2000-02-16 EP EP00903857A patent/EP1152768B1/en not_active Expired - Lifetime
- 2000-02-16 RU RU2001125429/14A patent/RU2001125429A/ru not_active Application Discontinuation
- 2000-02-16 AU AU25611/00A patent/AU766113B2/en not_active Ceased
- 2000-02-16 AT AT00903857T patent/ATE246930T1/de not_active IP Right Cessation
- 2000-02-16 AP APAP/P/2001/002254A patent/AP2001002254A0/en unknown
- 2000-02-16 US US09/913,523 patent/US6596282B1/en not_active Expired - Fee Related
- 2000-02-16 ES ES00903857T patent/ES2204508T3/es not_active Expired - Lifetime
- 2000-02-16 MX MXPA01008243A patent/MXPA01008243A/es unknown
- 2000-02-16 TR TR2001/02388T patent/TR200102388T2/xx unknown
- 2000-02-16 DE DE60004481T patent/DE60004481T2/de not_active Expired - Fee Related
- 2000-02-16 HU HU0105474A patent/HUP0105474A3/hu unknown
- 2000-02-16 CA CA002361925A patent/CA2361925A1/en not_active Abandoned
- 2000-02-16 DK DK00903857T patent/DK1152768T3/da active
- 2000-02-16 NZ NZ513320A patent/NZ513320A/en unknown
-
2001
- 2001-07-30 ZA ZA200106248A patent/ZA200106248B/en unknown
- 2001-08-14 NO NO20013939A patent/NO20013939L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| CA2361925A1 (en) | 2000-08-24 |
| NZ513320A (en) | 2004-04-30 |
| HUP0105474A3 (en) | 2003-11-28 |
| NO20013939L (no) | 2001-10-04 |
| JP2002537266A (ja) | 2002-11-05 |
| RU2001125429A (ru) | 2003-06-10 |
| AP2001002254A0 (en) | 2001-09-30 |
| HK1038697B (en) | 2004-03-19 |
| AU766113B2 (en) | 2003-10-09 |
| GB9903539D0 (en) | 1999-04-07 |
| EP1152768B1 (en) | 2003-08-13 |
| WO2000048615A3 (en) | 2000-12-14 |
| DE60004481D1 (de) | 2003-09-18 |
| PL350577A1 (en) | 2002-12-30 |
| ATE246930T1 (de) | 2003-08-15 |
| HK1038697A1 (en) | 2002-03-28 |
| HUP0105474A2 (hu) | 2002-05-29 |
| ES2204508T3 (es) | 2004-05-01 |
| ZA200106248B (en) | 2002-01-23 |
| CN1377274A (zh) | 2002-10-30 |
| KR20010113691A (ko) | 2001-12-28 |
| TR200102388T2 (tr) | 2002-10-21 |
| EP1152768A2 (en) | 2001-11-14 |
| US6596282B1 (en) | 2003-07-22 |
| WO2000048615A2 (en) | 2000-08-24 |
| DK1152768T3 (da) | 2003-11-24 |
| ID30441A (id) | 2001-12-06 |
| DE60004481T2 (de) | 2004-06-24 |
| AU2561100A (en) | 2000-09-04 |
| MXPA01008243A (es) | 2002-08-30 |
| PT1152768E (pt) | 2003-12-31 |
| NO20013939D0 (no) | 2001-08-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR9710355A (pt) | Composição útil para o tratamento de infecções virais em um mamìfero, processo para tratar uma infecção viral em um mamìfero, e, produto medicinal. | |
| WO2003051306A3 (en) | N4-acylcytosine-1,3-dioxolane nucleosides for treatment of viral infections | |
| HUP0003131A2 (hu) | Polietilénglikol/alfa-interferon konjugátumok fertőzés kezelésére | |
| EA200201279A1 (ru) | Способы и композиции для лечения вирусного гепатита c | |
| ES2051641B1 (es) | Procedimientos para la preparacion de compuestos derivados de tiourea. | |
| ATE475423T1 (de) | Immunostimulierende polynukleotide sequenzen zur verwendung bei der verhinderung und behandlung von viralen erkrankungen | |
| TW200509961A (en) | Uses of interferons for the treatment of severe acute respiratory syndrome and other viral infections | |
| AR023824A1 (es) | Terapia de hiv combinacion de antagonista ccr5-interferon alfa pegilado. | |
| WO2002034284A3 (en) | Methods of therapy for hiv infection | |
| PT1242119E (pt) | Combinacoes para o tratamento de infeccoes por virus adn incluindo um diuretico de ansa e um glicosido cardiotonico | |
| CY1105408T1 (el) | Χρησιμοποιηση στελεχων του ιου parapox ovis για την παρασκευη αντιικων φαρμακων και φαρμακων κατα του καρκινου | |
| CA2504872A1 (en) | Use of resveratrol for the preparation of a medicament useful for the treatment of influenza virus infections | |
| AR022250A1 (es) | Envase farmaceutico de uso para el tratamiento y prevencion de infecciones por el virus de la hepatitis b, procedimiento para el tratamiento de pacientes o pacientes susceptibles en padecer infecciones por el virus de la hepatitis b. | |
| BR0008269A (pt) | Uso de uma preparação de m. vaccae, e, método para tratamento de infecção viral crÈnica, excluindo infecção por hiv | |
| AR005750A1 (es) | Composicion farmaceutica para tratar o prevenir infecciones con zoster en personas infectadas con el virus de varicela zoster y procedimiento para preparar dicha composicion | |
| NZ512850A (en) | Treatment of papillomavirus infections | |
| WO2004033479A3 (en) | Retroyclins: antiviral and antimicrobial peptides | |
| BRPI0513321A (pt) | vìrus parapox em combinação com outros agentes antivirais para o tratamento de doenças virais | |
| WO2006045616A3 (en) | β-L-N4-HYDROXYCYTOSINE DEOXYNUCLEOSIDES AND THEIR USE AS PHARMACEUTICAL AGENTS IN THE PROPHYLAXIS OR THERAPY OF VIRAL DISEASES | |
| KR950702838A (ko) | 인터루킨-4(IL-4)를 사용한 사람 면역결핍 바이러스(HIV) 복제의 억제방법(Method for inhibiting HIV replication using IL-4) | |
| WO2001066100A3 (en) | Pharmaceutical composition | |
| BG100835A (bg) | Ново лекарствено средство за лечение на вирусни инфекции на дихателните пътища | |
| Siliciano | HARRT for life | |
| BR0207931A (pt) | Anticorpos naturais ativos contra vìrus hiv | |
| ES2195861T3 (es) | Uso de (ir,4s)-4-(6-amino-9h-purin-9-il)-2-ciclopenten-1-metanol en vhb. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 5A, 6A, 7A E 8A ANUIDADES. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1925 DE 27/11/2007. |